Is a complete IST/ONCSM research report available?

No complete published report is available for ist/ONCSM (IST/ONCSM) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

IST/ONCSM (IST/ONCSM)

Istanbul Stock Exchange: IST/ONCSM · TRY

TRY 253

-2.25 (-0.9%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-08-01 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first IST/ONCSM analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	6.1B
Revenue (ttm)	728.6M
Net income (ttm)	46.5M
EPS (ttm)	TRY 1.95
Shares out	23.9M
P/E (trailing)	130.8x
Volume	385,432
Beta	0.77

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 728.6M
Net income (ttm): 46.5M
EPS (ttm): TRY 1.95
P/E (trailing): 130.8x
Market cap: 6.1B

All IST/ONCSM indicators

Market & fundamental data

Available fields

181

Groups with data

Currency

TRY

Showing 181 of 181 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Turkey
Country code	TR
Employees	420
Employees Change	12%
Employees Change Percent	2.94
Enterprise value	TRY 6.2B
Exchange	Istanbul Stock Exchange
Financial currency	TRY
First seen	2026-05-10
Industry	Medical Devices
Isin	TREONCO00026
Last refreshed	2026-08-01
Market cap	TRY 6.1B
Price	TRY 253
Price currency	TRY
Rev Per Employee	1,734,673.46x
Sector	Healthcare
Sector PE	51.78
Sic	3841
Symbol	ist/ONCSM
Website	https://www.oncosem.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.76%
EV Earnings	132.99x
EV/EBIT	37.3x
EV/EBITDA	28.17x
EV/Sales	8.49x
FCF yield	-0.73%
P/B ratio	13.6x
P/E ratio	130.83x
P/S ratio	8.35x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	22.75%
EBITDA Margin	30.13%
Gross margin	48.71%
Gross Profit	TRY 354.9M
Gross Profit Growth	35.05%
Gross Profit Growth Q	36.84%
Gross Profit Growth3 Y	46.17%
Net Income	TRY 46.5M
Net Income Growth Q	-39.67%
Pretax Margin	9.26%
Profit Margin	6.38%
Profit Per Employee	TRY 110,677
ROA	17
ROCE	29.62
ROE	12.3
ROIC	22.94
Roic5y	18.08

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	168.78%
Cagr3y	18.44%
EPS Growth Q	-39.67
OCF Growth	-67.91%
OCF Growth3 Y	40.38%
Revenue Growth	20x
Revenue Growth Q	8.88x
Revenue Growth3 Y	29.82x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TRY 1.2
Assets	TRY 792.6M
Cash	TRY 56.2M
Current Assets	TRY 523.9M
Current Liabilities	TRY 233M
Debt	TRY 156.5M
Debt EBITDA	TRY 0.71
Debt Equity	TRY 0.35
Debt FCF	TRY -3.54
Equity	TRY 447.3M
Interest Coverage	3.89
Liabilities	TRY 345.3M
Long Term Assets	TRY 268.7M
Long Term Liabilities	TRY 112.3M
Net Cash	TRY -100.3M
Net Cash By Market Cap	TRY -1.65
Net Debt EBITDA	TRY 0.46
Net Debt Equity	TRY 0.22
Tangible Book Value	TRY 443.9M
Tangible Book Value Per Share	TRY 18.61
WACC	8.75

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.25
Inventory Turnover	3.36
Net Working Capital	TRY 354M
Quick ratio	1.72
Working Capital	TRY 290.9M
Working Capital Turnover	TRY 3.08

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend per share	TRY 0
Last Dividend	TRY 0.41

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	168.6%
200-day SMA	265.3
3Y total return	66.15%
50-day SMA	270.9
50-day SMA vs 200-day SMA	50over200
All Time High	389.8
All Time High Change	-35.15%
All Time High Date	2026-05-21
All Time Low	19.25
All Time Low Change	1,212.99%
All Time Low Date	2023-01-04
ATR	14.78
Beta	0.77
Beta1y	0.55
Beta2y	0.31
Ch YTD	-3.9
High	257.8
High52	389.8
High52 Date	2026-05-21
High52ch	-35.15%
Low	249.9
Low52	93.55
Low52 Date	2025-07-31
Low52ch	170.18%
Ma50ch	-6.7%
Price vs 200-day SMA	-4.72%
RSI	45.74
RSI Monthly	58.14
RSI Weekly	47.86
Sharpe ratio	1.84x
Sortino ratio	3.29
Tr YTD	-3.9
Tr1m	1.1%
Tr3m	-7.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TRY 165.8M
Operating Income Growth	112.2
Operating Income Growth Q	32.54
Operating Income Growth3 Y	82.04
Operating margin	22.75

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,395,000%
Net Borrowing	105,838,776
Shares Insiders	63.71%
Shares Institutions	5.17%
Shares Out	23,850,000
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	509,587.3x
Bv Per Share	18.75
CAPEX	TRY -86.6M
Ch1m	1.1
Ch1y	168.6
Ch3m	-7.59
Ch3y	65.74
Ch6m	-17
Change	-0.88%
Change From Open	-0.98
Close	255
Days Gap	0.1
Depreciation Amortization	53,723,868
Dollar Volume	97,417,938
Earnings Date	2026-08-11
EBIT	TRY 165.8M
EBITDA	TRY 219.5M
EPS	TRY 1.95
F Score	4
FCF	TRY -44.2M
FCF EV Yield	-0.72x
FCF Per Share	TRY -1.85
Financing CF	63,243,341
Fiscal Year End	December
Founded	2,008
Graham Number	28.67679
Graham Upside	-88.68
Income Tax	TRY 21M
Investing CF	-90,006,819
Is Primary Listing	1
Last Earnings Date	2026-02-18
Last Report Date	2026-03-31
Ma150	277.3
Ma150ch	-8.84%
Ma20	258.7
Ma20ch	-2.3%
Net CF	3,558,607
Next Earnings Date	2026-08-11
Open	255.3
P OCF Ratio	143.3
Position In Range	36.31
Ppne	226,223,604
Price Date	2026-07-31
Price EBITDA	TRY 27.71
Ptbv Ratio	13.7
Relative Volume	0.76x
Revenue	728,562,854x
Tax By Revenue	2.88x
Tax Rate	31.09%
Tr6m	-17%
Volume	385,432
Z Score	9.49

IST/ONCSM (IST/ONCSM)

Coverage state: Market snapshot only — no published research

Generate the first IST/ONCSM analysis

Price

Financial snapshot

Fair-value bridge

Latest news · IST/ONCSM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IST/ONCSM indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on IST/ONCSM

Frequently asked questions